跳至主要内容
临床试验/CTRI/2022/08/044729
CTRI/2022/08/044729已完成2 期

To evaluate the clinical efficacy of Trikatu and Haridra churna in the management of Medodushti(Dyslipidemia)

Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients between age group of 25 â?? 60 years in either sex.
  • Diagnosed and confirmed cases of Dyslipidemia (Medodushti) on the basis of criteria given by NCEP ATP III
  • Newly diagnosed case of NIDDM with optimal control Diabetes mellitus

排除标准

  • Patients with age below 25 year and above 60 years.
  • Patients have medical history of unstable angina, myocardial infarction, heart failure, stroke within 3 months of study, stage 2hypertension,stage 3 hypertension,type I diabetes mellitus, impaired renal function, hypothyroidism, jaundice, hepatitis, chronic infection and other serious diseases.
  • Pregnancy, lactation and patients having dyslipidemia due to drugs ex. Glucocorticoids, diuretics.
  • BMI >30Kg/m2
  • Patients not giving consent.

研究者

发起方
Institute of Medical Sciences

相似试验